BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 36207959)

  • 1. [Clinical features and survival analysis of microscopic polyangiitis-associated interstitial lung disease:a retrospective study of 28 patients].
    Wu TT; Cen ZK; Zhou HJ; Sun C; Tang P; Zhang Y; Ding QL
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Oct; 45(10):1022-1030. PubMed ID: 36207959
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical significance of acute exacerbation in interstitial lung disease with antineutrophil cytoplasmic antibody: an indicator of poor prognosis.
    Wu T; Zhang Y; Cen Z; Ying Y; Sun C; Lv C; Ding Q
    Ther Adv Respir Dis; 2022; 16():17534666221140974. PubMed ID: 36484348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of Interstitial Lung Disease and Prognosis in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Zhou P; Li Z; Gao L; Zhao B; Que C; Li H; Ma J; Wang G
    Respiration; 2023; 102(4):257-273. PubMed ID: 36693330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usual interstitial pneumonia in ANCA-associated vasculitis: A poor prognostic factor.
    Maillet T; Goletto T; Beltramo G; Dupuy H; Jouneau S; Borie R; Crestani B; Cottin V; Blockmans D; Lazaro E; Naccache JM; Pugnet G; Nunes H; de Menthon M; Devilliers H; Bonniaud P; Puéchal X; Mouthon L; Bonnotte B; Guillevin L; Terrier B; Samson M;
    J Autoimmun; 2020 Jan; 106():102338. PubMed ID: 31570253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and long-term outcomes of interstitial lung disease with anti-neutrophil cytoplasmic antibody.
    Sun X; Peng M; Zhang T; Li Z; Song L; Li M; Shi J
    BMC Pulm Med; 2021 Mar; 21(1):88. PubMed ID: 33726733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of radiological findings indeterminate for UIP pattern and anterior upper lobe honeycomb-like lesion in chronic fibrosing interstitial lung disease associated with MPO-ANCA.
    Yamakawa H; Sato S; Nakamura T; Nishizawa T; Kawabe R; Oba T; Horikoshi M; Akasaka K; Amano M; Kuwano K; Sasaki H; Matsushima H
    BMC Pulm Med; 2021 Nov; 21(1):346. PubMed ID: 34732182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival, causes of death, and prognostic factors for mortality in patients with microscopic polyangiitis and those with anti-neutrophil cytoplasmic antibody-positive interstitial lung disease: A single-center retrospective study.
    Takakuwa Y; Yamasaki Y; Matsushita H; Kiyokawa T; Mizushima M; Tonooka K; Nagafuchi H; Matsuoka S; Ooka S; Kawahata K
    Int J Rheum Dis; 2023 Mar; 26(3):446-453. PubMed ID: 36502537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiologic and pathologic characteristics of myeloperoxidase-antineutrophil cytoplasmic antibody-associated interstitial lung disease: a retrospective analysis.
    Baqir M; Yi EE; Colby TV; Cox CW; Ryu JH; Specks U
    Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(3):195-201. PubMed ID: 32476954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of microscopic polyangiitis with interstitial lung disease and bronchiectasis: probability of preexisting comorbidities.
    Zhang Y; Ding Q; Lv C; Ying Y; Cen Z; Zhou H; Wu T
    Ann Med; 2023 Dec; 55(1):2204449. PubMed ID: 37126372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interstitial lung disease and microscopic polyangiitis in chilean patients.
    Wurmann P; Sabugo F; Elgueta F; Mac-Namara M; Vergara K; Vargas D; Molina ML; Díaz JC; Gatica H; Goecke A
    Sarcoidosis Vasc Diffuse Lung Dis; 2020; 37(1):37-42. PubMed ID: 33093767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology.
    Manfredi A; Cassone G; Izzo R; Dallagiacoma G; Felicetti M; Cariddi A; Berti A; Giollo A; Nannini C; Bettio S; Monti S; Conticini E; Govoni M; Quartuccio L; Argolini LM; Kaleci S; Emmi G; Dejaco C; Padoan R; Dagna L; Rossini M; Cantini F; Montecucco C; Frediani B; De Vita S; Caporali R; Muratore F; Sebastiani M; Salvarani C;
    Clin Exp Rheumatol; 2023 Apr; 41(4):821-828. PubMed ID: 36200955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstitial Lung Disease in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Patients: Comparison With Idiopathic Pulmonary Fibrosis.
    Kwon M; Lee AS; Mira-Avendano I; Rojas CA; Grage R; Abril A
    J Clin Rheumatol; 2021 Dec; 27(8):324-330. PubMed ID: 32251058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical differences among patients with myeloperoxidase-antineutrophil cytoplasmic antibody-positive interstitial lung disease.
    Yamaguchi K; Yamaguchi A; Ito M; Wakamatsu I; Itai M; Muto S; Uno S; Aikawa M; Kouno S; Takemura M; Yatomi M; Aoki-Saito H; Koga Y; Hara K; Motegi S; Tsukida M; Ota F; Tsukada Y; Motegi M; Nakasatomi M; Sakairi T; Ikeuchi H; Kaneko Y; Hiromura K; Maeno T
    Clin Rheumatol; 2023 Feb; 42(2):479-488. PubMed ID: 36194347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
    Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
    Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and Patterns of Interstitial Lung Disease and Their Clinical Impact on Mortality in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Korean Single-Centre Observational Study.
    Ha JW; Pyo JY; Ahn SS; Song JJ; Park YB; Lee SW
    J Immunol Res; 2022; 2022():2499404. PubMed ID: 35655922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic Polyangiitis.
    Hozumi H; Kono M; Hasegawa H; Yasui H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Yokomura K; Nakamura H; Suda T
    Chest; 2021 Jun; 159(6):2334-2345. PubMed ID: 33571506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and prognosis of microscopic polyangiitis with usual interstitial pneumonia compared with idiopathic pulmonary fibrosis.
    Zhao W; Dai H; Liu Y; Zhu M; Bao N; Ban C; Zhang S; Ren Y; Ye Q; Wang C
    Clin Respir J; 2019 Jul; 13(7):460-466. PubMed ID: 31013398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of usual interstitial pneumonia with anti-neutrophil cytoplasmic antibody in comparison with idiopathic pulmonary fibrosis.
    Hosoda C; Baba T; Hagiwara E; Ito H; Matsuo N; Kitamura H; Iwasawa T; Okudela K; Takemura T; Ogura T
    Respirology; 2016 Jul; 21(5):920-6. PubMed ID: 26994375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias.
    Hozumi H; Oyama Y; Yasui H; Suzuki Y; Kono M; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Suda T
    PLoS One; 2018; 13(6):e0199659. PubMed ID: 29928060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in interstitial lung disease associated with primary Sjögren's syndrome: a retrospective analysis of 33 pathologically-proven cases.
    Enomoto Y; Takemura T; Hagiwara E; Iwasawa T; Fukuda Y; Yanagawa N; Sakai F; Baba T; Nagaoka S; Ogura T
    PLoS One; 2013; 8(9):e73774. PubMed ID: 24040065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.